|
|
583 Division Street Ste A
Campbell, California 95008 USA
phone:650 704 8382
fax:866-372-0899
|
|
| Symbol |
Private |
| Founded |
2007 |
| Employees |
3 |
|
|
| www.emkinetics.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Clinical-stage, medical device company developing neuromodulation technology |
|
| Management |
| Hugh Sharkey CEO,
Dan Burnett MD Executive Director,
Christopher Hermanson MD President,
Amit Rajguru MD Chief Medical Officer,
Rupesh Desai Vice President Engineering,
Jennifer Sharkey VP RA/CA & QA |
| |
|
|
| |
|
| Keywords |
| Medical Device, Neuromodulation, Urinary urge incontinence, EMkinetics, Overactive Bladder |
|
|
|
| Description |
|
EMKinetics is a medical device company developing a non-invasive neuromodulation technology, which is initially being developed for the treatment of urinary urge incontinence. The company's technology, TranStim� Neuromodulation System, is utilized to produce pelvic floor stimulation for amerlioration of urinary incontinence and overactive bladder. |
|
| Products / Services |
TranStim? Neuromodulation System
|
|
| Technology / Differentiation |
| Non-invasive neuromodulation for pelvic floor stimulation |
|
| Market / Customers |
Urologist, uro-gynecologist, etc.
|
|
| Competitors / Substitutes / Alternatives |
Medtronic Interstim Implantable,
Uroplasty - Urgent PC,
Anticholinergic Drugs
|
|
| Strategy |
Develop an in-office, non-invasive therapy for the treatment of urge incontinence - overactive bladder.
|
|
| Funding |
| Raising a second round of financing to conduct a pivotal clinical trial to support FDA 510(k) clearance.
The Company is currently seeking interested investors. |
|
| Status |
| Fund raising;
Pre-IDE meeting with FDA |
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members